David R. Gagnon, MD, PhD

Research Professor, Biostatistics
David Gagnon
(617) 638-5172gagnon@bu.edu
Crosstown Center – 328
View full profile at BUMC

Biography

David Gagnon, MD MPH PhD is Research Professor of Biostatistics. Dr. Gagnon is director of biostatistics in the division of Population Health and Data Science at the Massachusetts Veterans Epidemiology Research and Information Center [MAVERIC] located at the Boston VA hospital. Dr. Gagnon is also a biostatistician with the Million Veteran Program and the "All of Us" Precision Medicine Initiative. He currently teaches Categorical Data Analysis [BS821], Advanced Methods in Statistical Computing [BS822] and Applications of Statistical Methods in Clinical Research [BS775]. Dr Gagnon's research interests are in the areas of phenomics, pharmacoepidemiology, longitudinal data analysis, survival analysis and statistical computing.

Education

  • Tufts University, MD
  • Boston University School of Public Health, PhD
  • Boston University, MPH
  • Saint Anselm College, BA

Classes Taught

  • SPHBS821
  • SPHBS852
  • SPHBS852
  • SPHBS901
  • SPHBS902
  • SPHBS980
  • SPHBS980
  • SPHBS980

Publications

  • Published on 2/1/2018

    Dukhovny S, Van Bennekom CM, Gagnon DR, Hernandez Diaz S, Parker SE, Anderka M, Werler MM, Mitchell AA. Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study. Birth Defects Res. 2018 Feb 01. PMID: 29388358.

    Read at: PubMed
  • Published on 1/3/2018

    Vassy JL, Ho YL, Honerlaw J, Cho K, Michael Gaziano J, Wilson PWF, Gagnon DR. Yield and Bias In Defining a Cohort Study Baseline from Electronic Health Record Data. J Biomed Inform. 2018 Jan 03. PMID: 29305952.

    Read at: PubMed
  • Published on 9/27/2017

    Orkaby AR, Cho K, Cormack J, Gagnon DR, Driver JA. Metformin vs sulfonylurea use and risk of dementia in US veterans aged =65 years with diabetes. Neurology. 2017 Oct 31; 89(18):1877-1885. PMID: 28954880.

    Read at: PubMed
  • Published on 9/26/2017

    Wilson PWF, Gagnon D. Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual Care. Circulation. 2017 Sep 26; 136(13):1204-1206. PMID: 28947479.

    Read at: PubMed
  • Published on 8/8/2017

    Kerfoot BP, Gagnon DR, McMahon GT, Orlander JD, Kurgansky KE, Conlin PR. A Team-Based Online Game Improves Blood Glucose Control in Veterans With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care. 2017 Sep; 40(9):1218-1225. PMID: 28790131.

    Read at: PubMed
  • Published on 7/25/2017

    Wan ES, Kantorowski A, Homsy D, Teylan M, Kadri R, Richardson CR, Gagnon DR, Garshick E, Moy ML. Promoting physical activity in COPD: Insights from a randomized trial of a web-based intervention and pedometer use. Respir Med. 2017 Sep; 130:102-110. PMID: 29206627.

    Read at: PubMed
  • Published on 7/12/2017

    Frain L, Swanson D, Cho K, Gagnon D, Lu KP, Betensky RA, Driver J. Association of cancer and Alzheimer's disease risk in a national cohort of veterans. Alzheimers Dement. 2017 Dec; 13(12):1364-1370. PMID: 28711346.

    Read at: PubMed
  • Published on 4/20/2017

    Shantakumar S, Nordstrom BL, Hall SA, Djousse L, van Herk-Sukel MPP, Fraeman KH, Gagnon DR, Chagin K, Nelson JJ. Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting: Results From a Distributed Research Network. J Patient Saf. 2017 Apr 20. PMID: 28430700.

    Read at: PubMed
  • Published on 3/6/2017

    Wiltsey Stirman S, Finley EP, Shields N, Cook J, Haine-Schlagel R, Burgess JF, Dimeff L, Koerner K, Suvak M, Gutner CA, Gagnon D, Masina T, Beristianos M, Mallard K, Ramirez V, Monson C. Improving and sustaining delivery of CPT for PTSD in mental health systems: a cluster randomized trial. Implement Sci. 2017 03 06; 12(1):32. PMID: 28264720.

    Read at: PubMed
  • Published on 11/10/2016

    Wimmer NJ, Dufour AB, Cho K, Gagnon DR, Quach L, Ly S, Do JM, Ostrowski S, Michael Gaziano J, Faxon DP, Kinlay S. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):1176-1184. PMID: 27860195.

    Read at: PubMed

View 97 more publications:View full profile at BUMC